HomeLBank Stocks
Korro Bio, Inc.
Korro Bio, Inc.

Korro Bio, Inc. (KRRO)

24HHigh$12.1024HLow$9.09
$12.07
+0.28%

Last updated: 2026-10-23 10:09:30

K-Line Chart, actual market data is subject to the trading page.

Key Data

Prev. Open
$9.40
Prev. Close
$12.07
Prev. Day's Range
$9.09 - $12.10
52W Range
$5.20 - $42.70
Trading Volume
441.645K
MC
$136.801M
P/E Ratio
--
EPS
$-9.71

Company Overview

NASDAQ

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. The company is headquartered in Cambridge, Massachusetts.

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Headquarters60 FIRST STREET, CAMBRIDGE, MA, UNITED STATES, 02141
CountryUSA
Listing Date2019-10-03
Fiscal Year Ended2026-06-30
Shares Outstanding14.726M
CIK Code1703647

Financial Metrics

Indicator2026-06-302026-03-312025-12-312025-09-30
Income$0$0$1.292M$1.09M
Operating Expenses--$380K$649K--
Net Income-$18.916M-$19.625M-$50.042M-$18.061M
Net Profit Margin-----3873.2%-1657.0%
Earnings Per Share--$-1.69$-5.33$-1.92
EBITDA-$19.745M-$20.056M-$15.234M-$16.882M
Effective Tax Rate-0.6%-0.5%-1.3%--

FAQ

KRRO operates in the [Sector] sector, specifically focusing on [Industry]. The company specializes in [Core Business Details], driving revenue through [Main Revenue Drivers], making it a significant player within its industry.
KRRO's main revenue drivers include [Revenue Driver 1], [Revenue Driver 2], and [Revenue Driver 3]. These areas are supported by the company’s focus on [Specific Business Model Elements or Strategies], which have contributed to growth within their market.
KRRO competes with [Competitor 1], [Competitor 2], and [Competitor 3] within the [Industry]. These competitors also target similar markets, offering investors a comparison in terms of performance, innovation, and market share.
As of now, KRRO [does/does not] distribute dividends to its shareholders. If dividends are paid, it typically reflects the company’s focus on returning value to investors, while a lack of dividends may indicate a strategy of reinvesting earnings to support growth initiatives.
Key risks for KRRO include [Risk 1], [Risk 2], and [Risk 3]. These factors could impact the company’s performance, so potential investors should evaluate how KRRO is addressing these challenges in their operational strategy.
KRRO has opportunities in [Market Opportunity 1] and [Market Opportunity 2], driven by [Trends or Catalysts]. However, these opportunities also depend on market competition, regulatory landscapes, and the company's ability to execute its strategic plans efficiently.
KRRO’s valuation metrics, such as its price-to-earnings (P/E) ratio or price-to-sales (P/S) ratio, can be compared to industry averages. While [positive/negative] variances exist, these numbers provide a useful benchmark to assess whether the stock is undervalued or overvalued relative to similar companies.
Recent trends impacting KRRO’s industry include [Trend 1] and [Trend 2]. KRRO has responded by [Adaptation or Business Strategy], positioning itself to remain competitive and aligned with shifting market demands.
Risk Warning
  1. 1.Stock prices may fluctuate significantly; invest with caution. Past performance is not indicative of future results.
  2. 2.Digital asset trading involves multiple risks, including market and technical risks. Please make rational decisions and allocate assets wisely.
  3. 3.The information contained on this page is for reference only and does not constitute any investment advice.